BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23052041)

  • 1. α-Cleavage of cellular prion protein.
    Liang J; Kong Q
    Prion; 2012; 6(5):453-60. PubMed ID: 23052041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular prion protein regulates its own α-cleavage through ADAM8 in skeletal muscle.
    Liang J; Wang W; Sorensen D; Medina S; Ilchenko S; Kiselar J; Surewicz WK; Booth SA; Kong Q
    J Biol Chem; 2012 May; 287(20):16510-20. PubMed ID: 22447932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new paradigm for enzymatic control of α-cleavage and β-cleavage of the prion protein.
    McDonald AJ; Dibble JP; Evans EG; Millhauser GL
    J Biol Chem; 2014 Jan; 289(2):803-13. PubMed ID: 24247244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shedding light on prion disease.
    Glatzel M; Linsenmeier L; Dohler F; Krasemann S; Puig B; Altmeppen HC
    Prion; 2015; 9(4):244-56. PubMed ID: 26186508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein.
    Taylor DR; Parkin ET; Cocklin SL; Ault JR; Ashcroft AE; Turner AJ; Hooper NM
    J Biol Chem; 2009 Aug; 284(34):22590-600. PubMed ID: 19564338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration.
    Altmeppen HC; Prox J; Puig B; Dohler F; Falker C; Krasemann S; Glatzel M
    FEBS J; 2013 Sep; 280(18):4338-47. PubMed ID: 23413979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PrP overdrive: does inhibition of α-cleavage contribute to PrP(C) toxicity and prion disease?
    McDonald AJ; Millhauser GL
    Prion; 2014; 8(2):183-91. PubMed ID: 24721836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion protein "gamma-cleavage": characterizing a novel endoproteolytic processing event.
    Lewis V; Johanssen VA; Crouch PJ; Klug GM; Hooper NM; Collins SJ
    Cell Mol Life Sci; 2016 Feb; 73(3):667-83. PubMed ID: 26298290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity.
    Cissé MA; Sunyach C; Lefranc-Jullien S; Postina R; Vincent B; Checler F
    J Biol Chem; 2005 Dec; 280(49):40624-31. PubMed ID: 16236709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sheddase ADAM10 is a potent modulator of prion disease.
    Altmeppen HC; Prox J; Krasemann S; Puig B; Kruszewski K; Dohler F; Bernreuther C; Hoxha A; Linsenmeier L; Sikorska B; Liberski PP; Bartsch U; Saftig P; Glatzel M
    Elife; 2015 Feb; 4():. PubMed ID: 25654651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of Peptide Aptamers with Prion Protein Central Domain Promotes α-Cleavage of PrP
    Corda E; Du X; Shim SY; Klein AN; Siltberg-Liberles J; Gilch S
    Mol Neurobiol; 2018 Oct; 55(10):7758-7774. PubMed ID: 29460268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoform-specific contribution of protein kinase C to prion processing.
    Alfa Cissé M; Louis K; Braun U; Mari B; Leitges M; Slack BE; Fisher A; Auberger P; Checler F; Vincent B
    Mol Cell Neurosci; 2008 Nov; 39(3):400-10. PubMed ID: 18722532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The P's and Q's of cellular PrP-Aβ interactions.
    Westaway D; Jhamandas JH
    Prion; 2012; 6(4):359-63. PubMed ID: 22874673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoproteolytic processing of the mammalian prion glycoprotein family.
    Mays CE; Coomaraswamy J; Watts JC; Yang J; Ko KW; Strome B; Mercer RC; Wohlgemuth SL; Schmitt-Ulms G; Westaway D
    FEBS J; 2014 Feb; 281(3):862-76. PubMed ID: 24286250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and characterization of a novel cellular prion-derived quenched fluorimetric substrate of alpha-secretase.
    Cissé MA; Gandreuil C; Hernandez JF; Martinez J; Checler F; Vincent B
    Biochem Biophys Res Commun; 2006 Aug; 347(1):254-60. PubMed ID: 16806063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An optimized Western blot assay provides a comprehensive assessment of the physiological endoproteolytic processing of the prion protein.
    Vanni I; Iacobone F; D'Agostino C; Giovannelli M; Pirisinu L; Altmeppen HC; Castilla J; Torres JM; Agrimi U; Nonno R
    J Biol Chem; 2023 Feb; 299(2):102823. PubMed ID: 36565989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the prion protein in the internalization of α-synuclein amyloids.
    De Cecco E; Legname G
    Prion; 2018 Jan; 12(1):23-27. PubMed ID: 29308725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoproteolysis of cellular prion protein by plasmin hinders propagation of prions.
    Mays CE; Trinh THT; Telling G; Kang HE; Ryou C
    Front Mol Neurosci; 2022; 15():990136. PubMed ID: 36117913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal cleavage of cellular prion protein in the human brain.
    Laffont-Proust I; Faucheux BA; Hässig R; Sazdovitch V; Simon S; Grassi J; Hauw JJ; Moya KL; Haïk S
    FEBS Lett; 2005 Nov; 579(28):6333-7. PubMed ID: 16263114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taking advantage of physiological proteolytic processing of the prion protein for a therapeutic perspective in prion and Alzheimer diseases.
    Béland M; Roucou X
    Prion; 2014; 8(1):106-10. PubMed ID: 24335160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.